BP
Healthcare & Life Sciences
Braeburn Pharmaceuticals
United States
Braeburn Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, 1 tracked investor.
Active
1
Investors
About Braeburn Pharmaceuticals
Braeburn Pharmaceuticals is a company headquartered in the United States. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Braeburn Pharmaceuticals develops and commercializes treatments for opioid use disorder, including BRIXADI, an FDA-approved buprenorphine extended-release subcutaneous injection for moderate to severe opioid use disorder.
Explore Braeburn Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.